Axsome Therapeutics Inc (NASDAQ: AXSM) Could Achieve Gains In The Near Future

After Hours

It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Yahoo Finance discussed the stock recently as it posted Axsome Therapeutics to Present at the TD Cowen 44th Annual Healthcare Conference.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Stocks Info

Axsome Therapeutics Inc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of Axsome Therapeutics Inc is $3.98B. A total of 0.55 million shares were traded on the day, compared to an average of 701.98K shares.

Insider trades are also considered as indicators of how a stock will perform in the future, in addition to stock predictions. During the recent three months, AXSM has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 1 BUYs and 2 SELLs from insiders. Insiders purchased 11,016 shares during that period but sold 29,588.

In the most recent transaction, Coleman Mark sold 18,572 shares of AXSM for 75.18 per share on Sep 15. After the transaction, the Director now owns 403,856 company shares. In a previous transaction on Sep 15, Coleman Mark sold 11,016 shares at 75.19 per share. AXSM shares that Director owns now total 25,097.

Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. According to analysts who have offered 12-month price targets for AXSM in the last 3 months, the mean price target is $120.93 with high estimates of $180.00 and low estimates of $90.00. In terms of 52-week highs and lows, AXSM has a high of $98.40 and a low of $53.71.

As of this writing, AXSM has an earnings estimate of -$1.2 per share for the current quarter. EPS was calculated based on a consensus of 11 estimates, with a high estimate of -$0.99 per share and a lower estimate of -$1.39. The company reported an EPS of -$1.32 in the last quarter, which was -10.00% lower than expectations of -$1.2.

Balance Sheet Annually/Quarterly

As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. AXSM’s latest balance sheet shows that the firm has $86.47M in Cash & Short Term Investments as of fiscal 2021. There were $49.71M in debt and $23.07M in liabilities at the time. Its Book Value Per Share was $4.03, while its Total Shareholder’s Equity was $15.63M.

Analysts Opinion

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for AXSM is Buy with a score of 4.67.

Most Popular

Related Posts